Boots C E, Meister M, Cooper A R, Hardi A, Jungheim E S
Obstetrics & Gynecology, Washington University, 4444 Forest Park, Suite 3100, St. Louis, MO, 63108, USA.
Washington University, 660 Euclid Avenue, St. Louis, MO, 63110, USA.
J Assist Reprod Genet. 2016 Aug;33(8):971-80. doi: 10.1007/s10815-016-0721-5. Epub 2016 May 4.
The purpose of this study was to evaluate whether outcomes are different if controlled ovarian stimulation (COS) is started in the luteal phase rather than the follicular phase.
A systematic review and meta-analysis was performed. Sixteen studies were included in the qualitative analysis, and eight studies with a total of 338 women were included in the quantitative analysis.
Cycles initiated in the luteal phase were slightly longer (WMD 1.1 days, 95 % CI 0.39-1.9) and utilized more total gonadotropins (WMD 817 IU, 95 % CI 489-1144). However, no differences were noted in peak estradiol levels (WMD -411 pg/ml, 95 % CI -906-84.7) or in the total number of oocytes retrieved (WMD 0.52 oocytes, 95 % CI -0.74-1.7). There were slightly more mature oocytes retrieved in the luteal phase (WMD 0.77 oocytes, 95 % CI 0.21-1.3), and fertilization rates were significantly higher (WMD 10 %, 95 % CI 0.03-0.18). While only three studies reported pregnancy outcomes, no difference was noted in the FET pregnancy rates after COS in the luteal versus follicular phase (RR 0.95, 95 % CI 0.56-1.7). A post hoc power analysis revealed that a sample of this size was sufficient to detect a clinically meaningful difference of 2 oocytes retrieved with 93 % power.
Although initiating COS in the luteal phase requires a longer stimulation and a higher dose of total gonadotropin, these differences are not clinically significant. Furthermore, COS initiated in the luteal phase does not compromise the quantity or quality of oocytes retrieved compared to outcomes of traditional stimulation in the follicular phase.
本研究旨在评估在黄体期而非卵泡期开始进行控制性卵巢刺激(COS)时,结局是否有所不同。
进行了一项系统评价和荟萃分析。定性分析纳入了16项研究,定量分析纳入了8项研究,共338名女性。
在黄体期开始的周期略长(加权均数差[WMD] 1.1天,95%可信区间[CI] 0.39 - 1.9),且使用的促性腺激素总量更多(WMD 817国际单位,95% CI 489 - 1144)。然而,在雌二醇峰值水平(WMD -411皮克/毫升,95% CI -906 - 84.7)或获取的卵母细胞总数(WMD 0.52个卵母细胞,95% CI -0.74 - 1.7)方面未观察到差异。在黄体期获取的成熟卵母细胞略多(WMD 0.77个卵母细胞,95% CI 0.21 - 1.3),且受精率显著更高(WMD 10%,95% CI 0.03 - 0.18)。虽然只有三项研究报告了妊娠结局,但在黄体期与卵泡期进行COS后的冻融胚胎移植妊娠率方面未观察到差异(风险比[RR] 0.95,95% CI 0.56 - 1.7)。事后效能分析显示,该样本量足以以93%的效能检测到获取的卵母细胞有2个的临床有意义差异。
尽管在黄体期开始进行COS需要更长的刺激时间和更高剂量的促性腺激素总量,但这些差异在临床上并不显著。此外,与传统卵泡期刺激的结局相比,在黄体期开始进行COS不会损害获取的卵母细胞数量或质量。